IRON – disc medicine, inc. (US:NASDAQ)
Stock Stats
News
Disc Medicine (NASDAQ:IRON) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Disc Medicine (NASDAQ:IRON) had its price target raised by analysts at Wells Fargo & Company from $91.00 to $109.00. They now have an "overweight" rating on the stock.
Has Disc Medicine's 2025 Surge Already Gone Too Far After Pipeline Progress Fuels Rally? [Yahoo! Finance]
Disc Medicine (NASDAQ:IRON) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
Form 4 Disc Medicine, Inc. For: Dec 19 Filed by: Quisel John D
Form 4 Disc Medicine, Inc. For: Dec 17 Filed by: Bitterman Kevin
Form SCHEDULE 13D/A Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Form 144 Disc Medicine, Inc. Filed by: AI DMI LLC
Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund XII, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.